✦ LIBER ✦
Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: A prospective, multicenter phase II study
✍ Scribed by Hawk Kim; Jae-Hoo Park; Je-Hwan Lee; Jung-Hee Lee; Young-Don Joo; Won-Sik Lee; Sung-Hwa Bae; Hun Mo Ryoo; Kyoo-Hyung Lee
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 130 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.